SCHEMBL13619228

SCHEMBL13619228

Cc1ccc(-c2ncc[nH]c2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 1/20 0.56
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 1/20 0.45
ALOX5 P09917 1/20 0.43
TNKS O95271 1/20 0.42
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 1/20 0.39
ADORA3 P0DMS8 1/20 0.38
ADORA1 P30542 1/20 0.38
BRD4 O60885 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5065601 0.81 PDE3B (0.47) NISCHRAB9AKDM4ENPC1TNKS
SCHEMBL29948010 0.81 PDE3B (0.47) NISCHKDM4EALDH1A1MEN1KMT2A
SCHEMBL13619043 0.81 PDE3B (0.47) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL17151506 0.81 PDE3B (0.47) RAB9ABRD4
SCHEMBL5065569 0.81 MTOR (0.53) NISCHRAB9AKDM4ENPC1ALDH1A1
SCHEMBL15144399 0.81 PDE3B (0.51) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL6619540 0.73 DAO (0.42) NISCHRAB9AKDM4ENPC1ALDH1A1
SCHEMBL2904930 0.73 TDP1 (0.46) NISCHRAB9AKDM4ENPC1ALDH1A1
SCHEMBL674010 0.72 NISCH (1.00) NISCHRAB9AKDM4ENPC1ALOX5
SCHEMBL30719409 0.72 AURKA (0.40) NISCHALDH1A1SMN1; SMN2MAPTAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268624-B1 ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
WO-2009132739-A1 ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-11-05 WO disclosed